HIND Vyome Holdings, Inc.

-

Vyome Reported Earnings

Wednesday, August 12, 2026 · 12:00 AM ET

Vyome (HIND) reported a loss of $0.10 per share on revenue of $0.27 million for the second quarter ended June 2026. .

Vyome Therapeutics Inc. is a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases principally in the US. Vyome Therapeutics Inc., formerly known as ReShape Lifesciences Inc., is based in CAMBRIDGE, Mass.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.10)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth
Reported Revenue
$0.27M
Revenue Estimate
Revenue Surprise
Revenue Growth